ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
2.090
-0.030 (-1.42%)
Dec 5, 2025, 4:00 PM EST - Market closed
ProQR Therapeutics Employees
ProQR Therapeutics had 166 employees as of December 31, 2024. The number of employees increased by 10 or 6.07% compared to the previous year.
Employees
166
Change (1Y)
10
Growth (1Y)
6.07%
Revenue / Employee
$113,543
Profits / Employee
-$300,699
Market Cap
220.17M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PRQR News
- 5 days ago - ProQR to Participate in 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 4 weeks ago - ProQR Announces Third Quarter 2025 Operating and Financial Results - GlobeNewsWire
- 4 weeks ago - ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call Transcript - Seeking Alpha
- 6 weeks ago - ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 - GlobeNewsWire
- 7 weeks ago - ProQR to Participate in Upcoming Investor Conferences in October 2025 - GlobeNewsWire
- 4 months ago - ProQR Announces Second Quarter 2025 Operating and Financial Results - GlobeNewsWire
- 4 months ago - ProQR Announces Upcoming Presentation at RNA Editing Summit - GlobeNewsWire
- 5 months ago - ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP - GlobeNewsWire